Results of an anemia management program to reduce high epoetin doses by targeted use of i.v. ferric gluconate.

Nephrology nursing journal : journal of the American Nephrology Nurses' Association

Volumn 35, Issue 6, 2008, Pages 583-587

  Coyne, Daniel W ^a   Sims, Andrea ^a   Bingel, Brenda ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FERRIC GLUCONATE; FERRIC ION; RECOMBINANT ERYTHROPOIETIN;

ANEMIA; ARTICLE; CLINICAL TRIAL; COST BENEFIT ANALYSIS; DRUG COMBINATION; DRUG RESISTANCE; ECONOMICS; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; RENAL REPLACEMENT THERAPY;

ANEMIA; COST-BENEFIT ANALYSIS; DRUG RESISTANCE; DRUG THERAPY, COMBINATION; EPOETIN ALFA; FERRIC COMPOUNDS; HUMANS; INFUSIONS, INTRAVENOUS; RENAL DIALYSIS;

EID: 64249137714     PISSN: 1526744X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (0)